from Redacted.inc

Healthy people in the U.K. are being recruited to test an experimental Alzheimer’s drug that researchers say could prevent Alzheimer’s before any symptoms show up.

Who the hell signs up for that?

Researchers will screen adults between 55 and 80 for a blood biomarker called p-tau217. Only people whose results suggest they’re at elevated risk of developing Alzheimer’s will be invited into the trial.

So imagine feeling perfectly fine and then taking a blood test that tells you that you may have an elevated risk of developing Alzheimer’s. Would you rather wait and see what happens, or spend the next four to six years receiving IV infusions of an unapproved drug that might prevent it?

Oh, and some participants will receive a placebo.

The drug, trontinemab, is designed to clear amyloid plaques from the brain. Early studies suggest it can do that quickly, but researchers still don’t know whether clearing those plaques before symptoms begin will actually prevent dementia.

It can also cause infusion reactions and a condition called ARIA: inflammation, swelling or small areas of bleeding in the brain.

So, who the hell signs up for this?

Someone so terrified of Alzheimer’s that they’re willing to risk making their life a living hell.

What’s worse is that there is still no cure for Alzheimer’s, so if the drug doesn’t work, you’re essentially headed where you were already headed, only now you’ve spent years getting infusions and worrying about side effects.

No thanks.